Jerchel, I. S., Hoogkamer, A. Q., Ariës, I. M., Steeghs, E. M. P., Boer, J. M., Besselink, N. J. M., . . . den Boer, M. L. (2018). RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. Leukemia.
Citação norma ChicagoJerchel, I S., et al. "RAS Pathway Mutations As a Predictive Biomarker for Treatment Adaptation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia." Leukemia 2018.
MLA citiranjeJerchel, I S., et al. "RAS Pathway Mutations As a Predictive Biomarker for Treatment Adaptation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia." Leukemia 2018.
Opozorilo: Ti citati niso vedno 100% točni.